Yuyu Pharma Overview

  • Year Founded
  • 1941

Year Founded

  • Status
  • Public

  • Employees
  • 254

Employees

  • Stock Symbol
  • 000220

Stock Symbol

  • Investments
  • 5

  • Share Price
  • $2.84
  • (As of Friday Closing)

Yuyu Pharma General Information

Description

Yuyu Pharma Inc. manufactures and markets medicines. The product is the medicines for Alzheimer's, which accounts for 45% of total revenue. The company also engages in health aid foods, rental of oxygen generator and analysis of medicines.

Contact Information

Website
www.yuyu.co.kr
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Yuyu Building, 197 Dongho-ro
  • Jung-gu
  • Seoul, 04598
  • South Korea
+82
Primary Industry
Pharmaceuticals
Other Industries
Other Consumer Non-Durables
Stock Exchange
KRX
Vertical(s)
Corporate Office
  • Yuyu Building, 197 Dongho-ro
  • Jung-gu
  • Seoul, 04598
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Yuyu Pharma Stock Performance

As of 13-Nov-2026, Yuyu Pharma’s stock price is $2.84. Its current market cap is $44.8M with 15.7M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.84 $2.84 $2.30 - $3.46 $44.8M 15.7M 108K $0.53

Yuyu Pharma Financials Summary

As of 30-Jun-2026, Yuyu Pharma has a trailing 12-month revenue of $99M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 45,754 60,451 52,630 92,500
Revenue 99,480 98,996 97,584 104,944
EBITDA 13,946 11,840 13,091 1,394
Net Income 8,616 5,730 6,391 (5,492)
Total Assets 134,726 143,904 140,999 153,811
Total Debt 18,183 19,391 22,841 30,579
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Yuyu Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Yuyu Pharma‘s full profile, request access.

Request a free trial

Yuyu Pharma Patents

Yuyu Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025149851-A2 Methods for treating inflammatory diseases Inactive 12-Jan-2024
WO-2025149851-A3 Methods for treating inflammatory diseases Inactive 12-Jan-2024
CA-3170606-A1 Treatment of inflammatory diseases with peptides and pharmaceutical compositions Pending 05-Mar-2020
EP-4114430-A2 Treatment of inflammatory diseases with peptides and pharmaceutical compositions Inactive 05-Mar-2020
EP-4114430-A4 Treatment of inflammatory diseases with peptides and pharmaceutical compositions Inactive 05-Mar-2020 A61K38/08
To view Yuyu Pharma’s complete patent history, request access »

Yuyu Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Yuyu Pharma Investments (5)

Yuyu Pharma’s most recent deal was a Early Stage VC with Vetmab Bio for . The deal was made on 29-Sep-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Vetmab Bio 29-Sep-2026 Early Stage VC Other Commercial Services
James & Ella 04-Feb-2026 Later Stage VC Other Consumer Non-Durables
Dalan 02-Dec-2025 Later Stage VC Other Pharmaceuticals and Biotechnology
Dog PPL 09-Apr-2025 Later Stage VC Leisure Facilities
Yuyu Teijin Medicare 01-Jan-2006 Joint Venture Therapeutic Devices
To view Yuyu Pharma’s complete investments history, request access »

Yuyu Pharma ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Yuyu Pharma’s complete esg history, request access »

Yuyu Pharma FAQs

  • When was Yuyu Pharma founded?

    Yuyu Pharma was founded in 1941.

  • Where is Yuyu Pharma headquartered?

    Yuyu Pharma is headquartered in Seoul, South Korea.

  • What is the size of Yuyu Pharma?

    Yuyu Pharma has 254 total employees.

  • What industry is Yuyu Pharma in?

    Yuyu Pharma’s primary industry is Pharmaceuticals.

  • Is Yuyu Pharma a private or public company?

    Yuyu Pharma is a Public company.

  • What is Yuyu Pharma’s stock symbol?

    The ticker symbol for Yuyu Pharma is 000220.

  • What is the current stock price of Yuyu Pharma?

    As of 13-Nov-2026 the stock price of Yuyu Pharma is $2.84.

  • What is the current market cap of Yuyu Pharma?

    The current market capitalization of Yuyu Pharma is $44.8M.

  • What is Yuyu Pharma’s current revenue?

    The trailing twelve month revenue for Yuyu Pharma is $99M.

  • What is Yuyu Pharma’s annual earnings per share (EPS)?

    Yuyu Pharma’s EPS for 12 months was $0.53.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process